2024-09-02 - Analysis Report
## HCA Stock Analysis Report

**Company Overview:** HCA Healthcare, Inc. is a leading provider of healthcare services in the United States, operating a network of hospitals and other healthcare facilities.

**1. Performance Analysis**

* **Relative Performance:** HCA stock has significantly outperformed the S&P 500 (VOO) with a cumulative return of 170.42% compared to VOO's 89.66%. This outperformance is evident with a current relative divergence of 80.76, indicating that HCA has been outperforming the benchmark by a substantial margin. 

**2. Recent Price Action**

* **Moving Averages:** HCA's stock price is currently above all three moving averages: 5-day ($391.45), 20-day ($373.99), and 60-day ($348.09). This suggests a positive short-term trend.

**3. Technical Indicators**

* **RSI:**  The RSI of 99.19 is extremely high, indicating that the stock is significantly overbought.  
* **PPO:** The PPO of 0.22 suggests a strong bullish momentum.  
* **Delta_Previous_Relative_Divergence:** The recent 20-day relative divergence change of 1.17 suggests a potential short-term pullback due to the overbought condition.
* **Expected Return:** The expected return of 0.0% indicates no potential for growth in the near future, likely due to the already strong performance and overbought condition.

**4. Recent Earnings & Outlook**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | 17.49 B$ |
| 2024-05-02 | 6.01 | 17.34 B$ |
| 2023-10-26 | 3.98 | 16.21 B$ |
| 2023-08-02 | 4.35 | 15.86 B$ |
| 2024-07-29 | 4.35 | 15.86 B$ |

HCA has consistently exceeded revenue expectations in recent quarters. The latest earnings report for the quarter ending July 29, 2024, showed an EPS of 5.6, exceeding analyst estimates.  This strong performance reflects the company's robust healthcare services demand and effective operational strategies.

**5. Overall Analysis**

HCA stock has been a top performer, outpacing the S&P 500 by a significant margin.  While the stock is currently overbought and technical indicators suggest a potential pullback, the company's strong fundamentals and consistent earnings performance suggest a positive long-term outlook. However, investors should be cautious due to the current overbought condition and consider waiting for a potential dip in price before investing.

**6. Recommendation**

While HCA stock offers potential for long-term growth due to the strong fundamentals, the current overbought condition suggests waiting for a pullback before investing. Investors should monitor the price action and technical indicators closely, considering a buy-in strategy during a potential correction.